UGC Approved Journal no 63975

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 9 | Issue 1 | January 2022

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 2
February-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIREV06027


Registration ID:
311927

Page Number

165-170

Share This Article


Jetir RMS

Title

Complications in Indian Pharmaceutical Industry with Special Reference to Intellectual Property Rights

Abstract

The IPR is well known as concepts, innovations, and innovative jargons that are founded on the public inclination to seek property status. In order to allow IPR to derive commercial profits from their artistic effort or prestige, they grant elite rights to the inventors or creators of that property. There are several forms of protection against intellectual property such as patent, copyright, trademark, etc. Patent is the approval of an innovation that meets the worldwide creativity, non-obviousness and commercial use standards. In order to help identify, prepare, market, make and, thus, secure the innovation or imagination, IPR is a necessary prerequisite. Any industry should make progress by developing its own advanced IPR policies, management style, techniques, etc., based on its field of expertise. Currently, the pharmaceutical industry has established an IPR policy that requires better attention in the next century. This research focuses mainly on both the challenges of the companies and the opportunities that Indian Pharmaceutical companies have in the form of IPR. The common problems with IPR with particular regard to Indian Pharmaceutical companies have given this study greater opportunities. As Indian pharmaceutical firms are justly starting to invest in R&D and to produce their own patented molecules, it is irrefutable that they want to shield their innovation with patents. The Indian government should also promote and protect foreign corporations' patents. For the industry, and for research and development, patent protection and other types of intellectual property (IP) rights are essential. Without strong fortification companies have no incentives for research and development or the development of new, advanced medicines, particularly pharmaceutical companies.

Key Words

Clinical Trials, Intellectual Property Rights, Generic Drugs, Patent, Research & Development, Copyrights.

Cite This Article

"Complications in Indian Pharmaceutical Industry with Special Reference to Intellectual Property Rights", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 2, page no.165-170, February-2019, Available :http://www.jetir.org/papers/JETIREV06027.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Complications in Indian Pharmaceutical Industry with Special Reference to Intellectual Property Rights", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 2, page no. pp165-170, February-2019, Available at : http://www.jetir.org/papers/JETIREV06027.pdf

Publication Details

Published Paper ID: JETIREV06027
Registration ID: 311927
Published In: Volume 6 | Issue 2 | Year February-2019
DOI (Digital Object Identifier):
Page No: 165-170
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000175

Print This Page

Current Call For Paper

Jetir RMS